Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
RNA Editing02:23

RNA Editing

9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

23.0K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
23.0K
RNA Stability01:53

RNA Stability

33.9K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive analyses of DNA methylation and gene expression profiles of Kawasaki disease.

Journal of cellular biochemistry·2019
Same author

[Effect of Glucocorticoid Pulse Therapy on Short-term Prognosis of Anti-neutrophil Cytoplasmic Antibodies-associated Glomerulonephritis].

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae·2019
Same author

tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas.

International journal of cancer·2019
Same author

Intensity-modulated nanoplasmonic interferometric sensor for MMP-9 detection.

Lab on a chip·2019
Same author

[Modified Mclaughlin procedure combined with locking plate for posterior shoulder dislocation with fracture].

Zhongguo gu shang = China journal of orthopaedics and traumatology·2019
Same author

Stabilizing nickel-rich layered oxide cathodes by magnesium doping for rechargeable lithium-ion batteries.

Chemical science·2019

Related Experiment Video

Updated: Sep 2, 2025

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.1K

Research Progress for RNA Modifications in Physiological and Pathological Angiogenesis.

Hui-Ming Chen1,2, Hang Li1, Meng-Xian Lin1

  • 1Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.

Frontiers in Genetics
|August 8, 2022
PubMed
Summary

This review explores how RNA modifications, such as N6-methyladenosine (m6A), impact tumor angiogenesis. Aberrant RNA modifications are linked to cancer development and progression by regulating key factors.

Keywords:
RNA modificationsangiogenesism5Cm6Atumor

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.5K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.9K

Related Experiment Videos

Last Updated: Sep 2, 2025

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.1K
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.5K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.9K

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Oncology

Background:

  • RNA modifications are crucial epigenetic regulators involved in vital biological processes like embryogenesis and stem cell differentiation.
  • Advancements in sequencing and antibody technologies have revealed links between RNA modifications and human diseases, including cancer.
  • Aberrant RNA modifications can drive tumor angiogenesis by influencing angiogenesis-related factors.

Purpose of the Study:

  • To review recent research on specific RNA modifications and their regulators in the context of tumor angiogenesis.
  • To highlight the significant role and impact of RNA modifications in the development of tumors.

Main Methods:

  • Literature review of cutting-edge studies.
  • Focus on key RNA modifications: N6-methyladenosine (m6A), N5-methylcytosine (m5C), N7-methylguanosine (m7G), N1-methyladenosine (m1A), and pseudouridine (Ψ).
  • Analysis of the association between these modifications, their regulators, and tumor angiogenesis.

Main Results:

  • RNA modifications play a critical role in regulating angiogenesis-related factors.
  • Specific RNA modifications like m6A are implicated in promoting tumor vascularization.
  • The interplay between RNA modification regulators and angiogenesis is complex and multifaceted.

Conclusions:

  • RNA modifications are emerging as key players in tumor angiogenesis.
  • Targeting RNA modification pathways presents a potential therapeutic strategy for cancer treatment.
  • Further research is needed to fully elucidate the mechanisms by which RNA modifications influence tumor growth and metastasis.